210
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A Multicentre Study of the Clinical and Epidemiological Profile of Inflammatory Bowel Disease in Northeast Brazil

ORCID Icon, ORCID Icon, , , , , , ORCID Icon, , , ORCID Icon, , , , , & show all
Pages 87-99 | Received 10 Mar 2023, Accepted 15 Jun 2023, Published online: 21 Jun 2023

References

  • Ko CW, Singh S, Feuerstein JD, et al. AGA clinical practice guidelines on the management of mild-to-moderate ulcerative colitis. Gastroenterology. 2019;156(3):748–764. doi:10.1053/j.gastro.2018.12.009
  • Feuerstein JD, Isaacs KL, Schneider Y, et al. AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis. Gastroenterology. 2020;158(5):1450–1461. doi:10.1053/j.gastro.2020.01.006
  • Raine T, Bonovas S, Burisch J, et al. ECCO guidelines on therapeutics in ulcerative colitis: medical treatment. J Crohns Colitis. 2022;16(1):2–17. doi:10.1093/ecco-jcc/jjab178
  • Torres J, Bonovas S, Doherty G, et al. ECCO guidelines on therapeutics in Crohn’s disease: medical treatment. J Crohns Colitis. 2020;14(1):4–22. doi:10.1093/ecco-jcc/jjz180
  • Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140(6):1785–1794. doi:10.1053/j.gastro.2011.01.055
  • Vegh Z, Kurti Z, Lakatos PL. Epidemiology of inflammatory bowel diseases from west to east. J Dig Dis. 2017;18(2):92–98. doi:10.1111/1751-2980.12449
  • Mak WY, Zhao M, Ng SC, Burisch J. The epidemiology of inflammatory bowel disease: east meets west. J Gastroenterol Hepatol. 2020;35(3):380–389. doi:10.1111/jgh.14872
  • Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies [published correction appears in Lancet. 2020 Oct 3;396(10256):e56]. Lancet. 2017;390(10114):2769–2778. doi:10.1016/S0140-6736(17)32448-0
  • Ng SC, Kaplan GG, Tang W, et al. Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific. Am J Gastroenterol. 2019;114(1):107–115. doi:10.1038/s41395-018-0233-2
  • Selvaratnam S, Gullino S, Shim L, et al. Epidemiology of inflammatory bowel disease in South America: a systematic review. World J Gastroenterol. 2019;25(47):6866–6875. doi:10.3748/wjg.v25.i47.6866
  • Park J, Cheon JH. Incidence and prevalence of inflammatory bowel disease across Asia. Yonsei Med J. 2021;62(2):99–108. doi:10.3349/ymj.2021.62.2.99
  • Quaresma AB, Damiao AOMC, Coy CSR, et al. Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: a large population-based study. Lancet Reg Health Am. 2022;13:100298. doi:10.1016/j.lana.2022.100298
  • Du L, Ha C. Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol Clin North Am. 2020;49(4):643–654. doi:10.1016/j.gtc.2020.07.005
  • Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 montreal world congress of gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5A–36A. doi:10.1155/2005/269076
  • Queiro R, Rodríguez-Caminero S, Riestra S, de Francisco R, Pérez-Martínez I, Ballina J. Performance of two screening questionnaires for inflammatory arthritis in patients with inflammatory bowel disease. Biomed Res Int. 2018;2018:8618703. doi:10.1155/2018/8618703
  • Gasparini RG, Sassaki LY, Saad-Hossne R. Inflammatory bowel disease epidemiology in São Paulo State, Brazil [published correction appears in Clin Exp Gastroenterol. 2020 Jun 16;13:221]. Clin Exp Gastroenterol. 2018;11(11):423–429. doi:10.2147/CEG.S176583
  • Kotze PG, Steinwurz F, Francisconi C, et al. Review of the epidemiology and burden of ulcerative colitis in Latin America. Therap Adv Gastroenterol. 2020;13:1756284820931739. doi:10.1177/1756284820931739
  • Martins KR, Araújo JM, Ác C, Luiz-Ferreira A. Epidemiologic aspects of inflammatory bowel disease in the western region of Minas Gerais state. Arq Gastroenterol. 2021;58(3):377–383. doi:10.1590/S0004-2803.202100000-63
  • Lucendo AJ, Hervías D, Roncero Ó, et al. Epidemiology and temporal trends (2000–2012) of inflammatory bowel disease in adult patients in a central region of Spain. Eur J Gastroenterol Hepatol. 2014;26(12):1399–1407. doi:10.1097/MEG.0000000000000226
  • Jiang L, Xia B, Li J, et al. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis. 2006;12(3):212–217. doi:10.1097/01.MIB.0000201098.26450.ae
  • Gomes TNF, de Azevedo FS, Argollo M, Miszputen SJ, Ambrogini O Jr. Clinical and demographic profile of inflammatory bowel disease patients in a reference center of São Paulo, Brazil. Clin Exp Gastroenterol. 2021;14:91–102. doi:10.2147/CEG.S288688
  • da Silva BC, Lyra AC, Mendes CMC, et al. The demographic and clinical characteristics of ulcerative colitis in a Northeast Brazilian population. Biomed Res Int. 2015;2015:359130. doi:10.1155/2015/359130
  • Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021;18(1):56–66. doi:10.1038/s41575-020-00360-x
  • Soon IS, Molodecky NA, Rabi DM, Ghali WA, Barkema HW, Kaplan GG. The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis. BMC Gastroenterol. 2012;12(1):51. doi:10.1186/1471-230X-12-51
  • Li T, Qiu Y, Yang HS, et al. Systematic review and meta-analysis: association of a pre-illness Western dietary pattern with the risk of developing inflammatory bowel disease. J Dig Dis. 2020;21(7):362–371. doi:10.1111/1751-2980.12910
  • Departamento de informática do Sistema Único de Saúde do Brasil. Brasil: Ministério da Saúde. Available from: http://tabnet.datasus.gov.br/cgi/idb2012/a04b.htm. Accessed June 16, 2023.
  • Oliveira TC, Lima MM, Coelho CD, et al. Perfil clínico-epidemiológico de pacientes com Doença Inflamatória Intestinal internados no Hospital Universitário da Universidade Federal do Piauí [CLINICAL-EPIDEMIOLOGICAL PROFILE OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE HOSPITALIZED AT THE UNIVERSITY HOSPITAL OF THE FEDERAL UNIVERSITY OF PIAUÍ]. Jornal de Ciências da Saúde do Hospital Universitário da Universidade Federal do Piauí. 2018;1(1):34. doi:10.26694/2595-0290.1134-40
  • Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific crohn’s and colitis epidemiology study. Gastroenterology. 2013;145(1):158–165.e2. doi:10.1053/j.gastro.2013.04.007
  • Delmondes LM, Nunes MO, Azevedo AR, Oliveira MM, Coelho LE, Torres-Neto JD. Clinical and sociodemographic aspects of inflammatory bowel disease patients. Gastroenterol Res. 2015;8(3–4):207–215. doi:10.14740/gr649w
  • Dall’Oglio VM, Balbinot RS, Muscope AL, et al. Epidemiological profile of inflammatory bowel disease in Caxias do Sul, Brazil: a cross-sectional study. Sao Paulo Med J. 2020;138(6):530–536. doi:10.1590/1516-3180.2020.0179.r2.10092020
  • Parente JM, Coy CS, Campelo V, et al. Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil. World J Gastroenterol. 2015;21(4):1197–1206. doi:10.3748/wjg.v21.i4.1197
  • Santos RM, Carvalho AT, Silva KD, et al. Inflammatory bowel disease: outpatient treatment profile. Arq Gastroenterol. 2017;54(2):96–100. doi:10.1590/s0004-2803.201700000-01
  • Cantoro L, Di Sabatino A, Papi C, et al. The time course of diagnostic delay in inflammatory bowel disease over the last sixty years: an Italian multicentre study. J Crohns Colitis. 2017;11(8):975–980. doi:10.1093/ecco-jcc/jjx041
  • Burisch J, Pedersen N, Čuković-čavka S, et al. East-west gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut. 2014;63(4):588–597. doi:10.1136/gutjnl-2013-304636
  • Vavricka SR, Spigaglia SM, Rogler G, et al. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18(3):496–505. doi:10.1002/ibd.21719
  • Beaugerie L, Massot N, Carbonnel F, Cattan S, Gendre JP, Cosnes J. Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol. 2001;96(7):2113–2116. doi:10.1111/j.1572-0241.2001.03944.x
  • Higuchi LM, Khalili H, Chan AT, Richter JM, Bousvaros A, Fuchs CS. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol. 2012;107(9):1399–1406. doi:10.1038/ajg.2012.196
  • Childers RE, Eluri S, Vazquez C, Weise RM, Bayless TM, Hutfless S. Family history of inflammatory bowel disease among patients with ulcerative colitis: a systematic review and meta-analysis. J Crohns Colitis. 2014;8(11):1480–1497. doi:10.1016/j.crohns.2014.05.008
  • Li X, Song P, Li J, et al. The disease burden and clinical characteristics of inflammatory bowel disease in the Chinese population: a systematic review and meta-analysis. Int J Environ Res Public Health. 2017;14(3):238. doi:10.3390/ijerph14030238
  • De Brito CA. The most relevant extraintestinal manifestations of inflammatory bowel disease: a multidisciplinary approach. Gastroenterol Hepatol Res. 2021;6(1). doi:10.24966/ghr-2566/100036
  • Park SK, Wong Z, Park SH, et al. Extraintestinal manifestation of inflammatory bowel disease in Asian patients: a multinational study. Dig Liver Dis. 2021;53(2):196–201. doi:10.1016/j.dld.2020.06.046
  • Algaba A, Guerra I, Ricart E, et al. Extraintestinal manifestations in patients with inflammatory bowel disease: study based on the ENEIDA registry. Dig Dis Sci. 2021;66(6):2014–2023. doi:10.1007/s10620-020-06424-x
  • Conigliaro P, Chimenti MS, Ascolani M, et al. Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients. Autoimmun Rev. 2016;15(2):184–190. doi:10.1016/j.autrev.2015.11.002
  • Cury DB, Oliveira R, Cury MS. Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management - a follow-up study in a private inflammatory bowel disease center (2003–2017). J Inflamm Res. 2019;12:127–135. doi:10.2147/JIR.S190929
  • Arantes JA, Santos CH, Delfino BM, et al. Epidemiological profile and clinical characteristics of patients with intestinal inflammatory disease. J Coloproctology. 2017;37(4):273–278. doi:10.1016/j.jcol.2017.06.004
  • Lamb CA, Kennedy NA, Raine T, et al. British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults [published correction appears in Gut. 2021 Apr;70(4):1]. Gut. 2019;68(Suppl 3):s1–s106. doi:10.1136/gutjnl-2019-318484
  • Singh S, Allegretti JR, Siddique SM, Terdiman JP. AGA technical review on the management of moderate to severe ulcerative colitis. Gastroenterology. 2020;158(5):1465–1496.e17. doi:10.1053/j.gastro.2020.01.007
  • Park SJ, Kim WH, Cheon JH. Clinical characteristics and treatment of inflammatory bowel disease: a comparison of eastern and western perspectives. World J Gastroenterol. 2014;20(33):11525–11537. doi:10.3748/wjg.v20.i33.11525